002424 Guizhou Bailing Group Pharmaceutical
- 3.51
- -0.18-4.88%
Guizhou Bailing Group Pharmaceutical News
Guizhou Bailing Group Pharmaceutical: Stock trading has experienced abnormal fluctuations announcement.
Guizhou Bailing Group Pharmaceutical: Announcement regarding the company and related responsible parties receiving the administrative regulatory measures decision.
Guizhou Bailing Group Pharmaceutical: Announcement on the reply to the inquiry letter of 2023 annual report of Shenzhen Stock Exchange.
Guizhou Bailing Group Pharmaceutical: Special Explanation of the Inquiry Letter from Tianjian Certified Public Accountants (Special General Partnership)
Guizhou Bailing Group Pharmaceutical: Announcement regarding the progress of repurchasing company shares.
Guizhou Bailing Group Pharmaceutical: Notice of abnormal fluctuations in stock trading
Guizhou Bailing Group Pharmaceutical: Notice of abnormal fluctuations in stock trading
Guizhou Bailing Group Pharmaceutical: Progress announcement on the repurchase of the company's shares to reach 1%
Guizhou Bailing Group Pharmaceutical: Legal Opinion (Guizhou Bailing 2023 Annual General Meeting of Shareholders)
Guizhou Bailing Group Pharmaceutical: Announcement on the resolution of the 2023 Annual General Meeting of Shareholders
Guizhou Bailing Group Pharmaceutical: Announcement on pledging some of the shares of the controlling shareholder
Guizhou Bailing Group Pharmaceutical: Notice of abnormal fluctuations in stock trading
Guizhou Bailing Group Pharmaceutical: 002424ST Bering Investor Relations Management Information 20240510
Guizhou Bailing Group Pharmaceutical: Notice of abnormal fluctuations in stock trading
Guizhou Bailing Group Pharmaceutical: Announcement on the progress of the repurchase of the company's shares
Guizhou Bailing Group Pharmaceutical: Legal Opinion (Guizhou Bailing 2024 Second Extraordinary General Meeting of Shareholders)
Guizhou Bailing Group Pharmaceutical: Announcement on attending the 2024 Guizhou Listed Company Investor Group Reception Day and 2023 Annual Results Briefing
Guizhou Bailing Group Pharmaceutical: Announcement on the resolution of the 2024 Second Extraordinary General Meeting of Shareholders
Guizhou Bailing Group Pharmaceutical: Announcement on cancellation of repurchased shares, reduction of registered capital and notification to creditors
Guizhou Bailing Group Pharmaceutical: Announcement on the deferral of repurchase of some of the controlling shareholders' shares by pledges
Analysis
Price Target
No Data
